SHINE-ON BIOMEDICAL CO., LTD.
Area: Incubation
Booth No: N715
Website: https://www.shineon-bio.com/
Exhibitor Profile
Shine-On Biomedical Co., Ltd., a new drug development company, was established in April 2021. Focusing on the best cancer treatment strategy for patients, Shine-On Biomedical has two major patented technology platforms: “Tri-Specific Antibody with T-cell Engager” technology platform & “Targeted Exosome for Drug Delivery” technology platform, a total of 5 "First-in-Human" drugs have been developed.
Brands
“Tri-Specific Antibody with T-cell Engager” technology platform & “Targeted Exosome for Drug Delivery” technology platform
Exhibit Products
-
EphA10-Trispecific Antibody of T & NK cell Engager
-
Gene-engineering MSCs-derived exosomes
-
HLA-G Targeted Exosome Delivering MicroRNA Drug
-
HLA-G Targeted Exosome Delivering Anticancer Drug
-
Nanobody based Trispecific Antibody of T cell Engager
Exhibitors you may be interested in
Highest Rated